Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0003 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0004 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.008 |
mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.009 |
mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.009 |